IMPQ Perennial Better Future Fund
- 4.910
- +0.060+1.24%
Jefferies Sticks to Their Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)
Arena REIT (ARF) Was Downgraded to a Hold Rating at UBS
NIB Holdings Ltd (3GU) Gets a Buy From UBS
Jarden Research Adjusts Telix Pharmaceuticals' Price Target to AU$16.62 From AU$13.94, Keeps at Buy
Analysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF), CSL (OtherCMXHF) and Telix Pharmaceuticals Ltd. (OtherTLPPF)
Jarden Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
Jarden Research Adjusts AUB Group's Price Target to AU$33.35 From AU$33.85, Keeps at Overweight
Telix Pharmaceuticals Ltd. (TLPPF) Gets a Buy From Wilsons
UBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
Analysts Offer Insights on Financial Companies: BAWAG Group AG (DE:0B2), HSBC Holdings (GB:HSBA) and NIB Holdings Ltd (Frankfurt: DE:3GU)
Bell Potter Downgrades Telix Pharmaceuticals Ltd. (TLPPF) to a Hold
Bell Potter Downgrades Telix Pharmaceuticals to Hold From Buy, Price Target Is AU$14.50
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
Jarden Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
UBS Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 From AU$13.27, Keeps at Buy
Analysts Are Bullish on These Healthcare Stocks: Tenaya Therapeutics (TNYA), Telix Pharmaceuticals Ltd. (TLPPF)
Wilsons Keeps Their Buy Rating on Telix Pharmaceuticals Ltd. (TLPPF)
Morgan Stanley Adjusts Nib Holdings' Price Target to AU$7.35 From AU$8.15, Keeps at Equalweight
Jarden Research Downgrades Steadfast Group to Neutral From Overweight, Adjusts Price Target to AU$6.10 From AU$6.25